Other Tumors
Atled (Fanregratinib) – Intrahepatic Cholangiocarcinoma | HongKong DengYue Medicine
Yizekang (Izalontamab Brengitecan) – NPC/ESCC | HongKong DengYue Medicine
Megace (Megestrol Acetate) – Anorexia | HongKong DengYue Medicine
Qingweishi (Everolimus) – Oncology | HongKong DengYue Medicine
Hansizhuang (Serplulimab) – Solid Tumors | HongKong DengYue Medicine
CIMAher (Nimotuzumab) – HNSCC | HongKong DengYue Medicine
Dacogen (Decitabine) – Hematologic Malignancies | HongKong DengYue Medicine
Haiyitan (Glumetinib) – Lung Cancer (NSCLC) | HongKong DengYue Medicine
Andewei (Benmelstobart) – ES-SCLC | HongKong DengYue Medicine
JAKAVI (Ruxolitinib) – MF/GVHD | HongKong DengYue Medicine
Qibeian (Iparomlimab Tuvorlimab) – Cervical Cancer | HongKong DengYue Medicine
Aitan (Apatinib) – Gastric Cancer | HongKong DengYue Medicine
Margenza (Margetuximab) – HER2 | HongKong DengYue Medicine
Orthocone OKT3 (Muromonab-CD3) – Prevention and Treatment of Acute Rejection | HongKong DengYue Medicine
Tongao (Calcium Leucovorin) – Folinic Acid Rescue | HongKong DengYue Medicine
Zytiga (Abiraterone Acetate) – mCRPC/mCSPC | HongKong DengYue Medicine
